Announcements and Notices - [Other - Business Update]

Jacobio Pharmaceuticals Co. Ltd. operates as a biotech company. The Company develops and sells cancer innovative drugs, autoimmune drugs, infectious diseases drugs, and other products. Jacobio Pharmaceuticals markets its products throughout China.

Voluntary Announcement  
Jacobio Received Upfront Payment Upon The Capital Increase Agreement And Equity Transfer Agreement

Voluntary Announcement  
Jacobio'S Kras G12c And Shp2 Combination Therapy Published In The Lancet Respiratory Medicine

Next Day Disclosure Returns - [Share Buyback]

Next Day Disclosure Return

Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change in Chief Executive]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Jacobio Pharmaceuticals (1167 HK)

Voluntary Announcement Jacobio Received Upfront Payment Upon The Capital Increase Agreement And Equity Transfer Agreement

Voluntary Announcement Jacobio'S Kras G12c And Shp2 Combination Therapy Published In The Lancet Respiratory Medicine

Next Day Disclosure Return

Appointment Of Co-Chief Executive Officer

Next Day Disclosure Return

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)